Hambleton Julie
IGM Biosciences, Inc. · Director
Hambleton Julie is listed in filings as Director at IGM Biosciences, Inc.. This profile follows SEC Form 4 activity through Aug 14, 2025, including sale activity. Recent filings connect the profile to IGM Biosciences, Inc. (IGMS), SPRINGWORKS THERAPEUTICS INC (SWTX), and Erasca, Inc. (ERAS). The current snapshot covers public activity from Jun 21, 2024 to Aug 14, 2025. Reported amounts are shown as $557.8K to $542.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $730k13.8k shares | SellFeb 10, 2025 | $53.01 | $46.99 |